Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: jgideon who wrote (1682)	11/30/1999 2:58:00 PM
From: Bo Didley	Read Replies (1) \| Respond to of 5582

GUMM Investors WebSite gumminvestors.com this is a good place to start researching GUMM as an investment. Also, zicam.com and gum-tech.com ---- look under products and see their various functional gums. bo

To: jgideon who wrote (1682)	11/30/1999 7:17:00 PM
From: DanZ	Respond to of 5582

jg, Gel Tech LLC owns the intellectual property rights to Zicam. Gum Tech owns 60% of Gel Tech LLC and Biodelivery Technologies owns the other 40%. Zicam is currently manufactured under contract by Botanicals and delivered to Gum Tech's warehouse in Phoenix. Gum Tech employees then ship individual boxes or display stands to retailers, whichever the retailer prefers. Theoretically, the bottle is correct because Zicam was developed by Gel Tech and is distributed by Gum Tech. There may be some costs to increase production, but I'm fairly certain that these will be the responsibility of Botanicals and aren't material. I hope to verify this soon. Please let us know how your cold is doing. I hope you feel better soon. Best regards, Dan